HC Wainwright & Co. reiterated coverage on TG Therapeutics with a new price target
$TGTX
Biotechnology: Pharmaceutical Preparations
Health Care
HC Wainwright & Co. reiterated coverage of TG Therapeutics with a rating of Buy and set a new price target of $68.00 from $70.00 previously